These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36689672)

  • 1. Mitochondrial creatine sensitivity is lost in the D2.
    Bellissimo CA; Delfinis LJ; Hughes MC; Turnbull PC; Gandhi S; DiBenedetto SN; Rahman FA; Tadi P; Amaral CA; Dehghani A; Cobley JN; Quadrilatero J; Schlattner U; Perry CGR
    Am J Physiol Cell Physiol; 2023 May; 324(5):C1141-C1157. PubMed ID: 36689672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H
    Hughes MC; Ramos SV; Turnbull PC; Rebalka IA; Cao A; Monaco CMF; Varah NE; Edgett BA; Huber JS; Tadi P; Delfinis LJ; Schlattner U; Simpson JA; Hawke TJ; Perry CGR
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):643-661. PubMed ID: 30938481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitohormesis during advanced stages of Duchenne muscular dystrophy reveals a redox-sensitive creatine pathway that can be enhanced by the mitochondrial-targeting peptide SBT-20.
    Hughes MC; Ramos SV; Brahmbhatt AN; Turnbull PC; Polidovitch NN; Garibotti MC; Schlattner U; Hawke TJ; Simpson JA; Backx PH; Perry CG
    Redox Biol; 2024 Oct; 76():103319. PubMed ID: 39178732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.
    Bellissimo CA; Gandhi S; Castellani LN; Murugathasan M; Delfinis LJ; Thuhan A; Garibotti MC; Seo Y; Rebalka IA; Hsu HH; Sweeney G; Hawke TJ; Abdul-Sater AA; Perry CGR
    Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1011-C1026. PubMed ID: 38145301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairments in left ventricular mitochondrial bioenergetics precede overt cardiac dysfunction and remodelling in Duchenne muscular dystrophy.
    Hughes MC; Ramos SV; Turnbull PC; Edgett BA; Huber JS; Polidovitch N; Schlattner U; Backx PH; Simpson JA; Perry CGR
    J Physiol; 2020 Apr; 598(7):1377-1392. PubMed ID: 30674086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.
    Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J
    J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.
    Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC
    J Pathol; 2012 Sep; 228(1):77-87. PubMed ID: 22653783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic targeting of mitochondria in muscular dystrophies. Editorial focus on: "Mitochondrial creatine sensitivity is lost in the D2.
    Juracic ES; Brahmbhatt AN; Hawke TJ
    Am J Physiol Cell Physiol; 2023 Aug; 325(2):C563-C564. PubMed ID: 37458438
    [No Abstract]   [Full Text] [Related]  

  • 9. Sensorimotor control of breathing in the mdx mouse model of Duchenne muscular dystrophy.
    Burns DP; Roy A; Lucking EF; McDonald FB; Gray S; Wilson RJ; Edge D; O'Halloran KD
    J Physiol; 2017 Nov; 595(21):6653-6672. PubMed ID: 28952155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body clearing, staining and screening of calcium deposits in the mdx mouse model of Duchenne muscular dystrophy.
    Bozycki L; Łukasiewicz K; Matryba P; Pikula S
    Skelet Muscle; 2018 Jul; 8(1):21. PubMed ID: 30025544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of respiratory function in mdx mice co-treated with neutralizing interleukin-6 receptor antibodies and urocortin-2.
    Burns DP; Canavan L; Rowland J; O'Flaherty R; Brannock M; Drummond SE; O'Malley D; Edge D; O'Halloran KD
    J Physiol; 2018 Nov; 596(21):5175-5197. PubMed ID: 30160301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diaphragm muscle fibrosis involves changes in collagen organization with mechanical implications in Duchenne muscular dystrophy.
    Sahani R; Wallace CH; Jones BK; Blemker SS
    J Appl Physiol (1985); 2022 Mar; 132(3):653-672. PubMed ID: 35050792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy.
    Hammers DW; Hart CC; Matheny MK; Wright LA; Armellini M; Barton ER; Sweeney HL
    Sci Rep; 2020 Aug; 10(1):14070. PubMed ID: 32826942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inspiratory pressure-generating capacity is preserved during ventilatory and non-ventilatory behaviours in young dystrophic mdx mice despite profound diaphragm muscle weakness.
    Burns DP; Murphy KH; Lucking EF; O'Halloran KD
    J Physiol; 2019 Feb; 597(3):831-848. PubMed ID: 30570134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation.
    Barker RG; Wyckelsma VL; Xu H; Murphy RM
    Am J Physiol Cell Physiol; 2018 Apr; 314(4):C483-C491. PubMed ID: 29351413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
    Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC
    Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A long-term treatment with taurine prevents cardiac dysfunction in mdx mice.
    Mele A; Mantuano P; De Bellis M; Rana F; Sanarica F; Conte E; Morgese MG; Bove M; Rolland JF; Capogrosso RF; Pierno S; Camerino GM; Trabace L; De Luca A
    Transl Res; 2019 Feb; 204():82-99. PubMed ID: 30347179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in calsequestrin, TNF-α, TGF-β and MyoD levels during the progression of skeletal muscle dystrophy in mdx mice: a comparative analysis of the quadriceps, diaphragm and intrinsic laryngeal muscles.
    Barros Maranhão J; de Oliveira Moreira D; Maurício AF; de Carvalho SC; Ferretti R; Pereira JA; Santo Neto H; Marques MJ
    Int J Exp Pathol; 2015 Oct; 96(5):285-93. PubMed ID: 26515458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.